{"issuance_frequency":"","notes_translated":{"fr":"L'AU 2 maintient en place la voie d'autorisation facultative établie par le premier AU pour faciliter les essais cliniques portant sur d'éventuels médicaments et instruments médicaux liés à la COVID-19. ","en":"IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"f8a3cdc2-cc16-4829-a3ba-3501ecc7e0a5","metadata_created":"2021-05-28T16:10:58.664231","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-05-28T16:10:58.664238","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-05-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","ordonnance provisoire n ° 2","avis","essais cliniques","dispositifs médicaux","médicaments","autorisation de mener des essais cliniques"],"en":["COVID-19","Interim Order No. 2","notice","clinical trials","medical devices","drugs","authorization to conduct clinical trials"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Arrêté d’urgence no 2 sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19 : Avis","en":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"f8a3cdc2-cc16-4829-a3ba-3501ecc7e0a5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c8f0f1fc-f884-4ac4-833c-adf988f6d890","related_relationship":"","name_translated":{"fr":"Arrêté d’urgence no 2 sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19 : Avis","en":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice","language":["en"],"created":"2021-05-28T16:10:58.780811","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs/notice.html","last_modified":null,"position":0,"revision_id":"f793d22b-ffb6-470f-b464-28b4a31764c2","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"f8a3cdc2-cc16-4829-a3ba-3501ecc7e0a5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"aa8cf29b-f83c-4515-8692-cb949511a0b3","related_relationship":"","name_translated":{"fr":"Arrêté d’urgence no 2 sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19 : Avis","en":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice","language":["fr"],"created":"2021-05-28T16:10:58.780817","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/arrete-urgence-no-2-cliniques-instruments-medicaux-drogues/note-explanative/avis.html","last_modified":null,"position":1,"revision_id":"f793d22b-ffb6-470f-b464-28b4a31764c2","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-05-03 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"f8a3cdc2-cc16-4829-a3ba-3501ecc7e0a5","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice","revision_id":"f793d22b-ffb6-470f-b464-28b4a31764c2"}